Additional file 1: Table S1. of CXC chemokine superfamily induced by Interferon-Îł in asthma: a cross-sectional observational study

Characteristics of subjects classified by clinical severity according to International ERS/ATS guidelines. (XLSX 12 kb

Multivariate analysis of the risk of mortality in the study patients.

<p>Multivariate analysis of the risk of mortality in the study patients.</p

Etiology of pneumonia in the RA and non-RA patients.

<p>Etiology of pneumonia in the RA and non-RA patients.</p

Etiology of pneumonia in RA.

<p>Etiology of pneumonia in RA.</p

Characteristics of the patients with and without RA.

<p>Characteristics of the patients with and without RA.</p

Additional file 1 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 1. Identification of organisms in ventilator-associated pneumoniacase

Additional file 6 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 6. Admission to intensive care unitand use of invasive mechanical ventilationof bacterial respiratory infection with coronavirus disease 2019

Additional file 4 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 4. Details of respiratory secondary infection

Additional file 2 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 2. Evaluation of white blood cells, neutrophils, lymphocytes, neutrophil-lymphocyte ratio, C-reactive protein, and procalcitonin on admission as predictors of respiratory bacterial co-infection based on the area under the curv

Additional file 7 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 7. Forest plot of adjusted oddsratios by multivariate logistic regression analysis of risk factors of death in patients of coronavirus disease 2019with secondary infection except ventilator-associated pneumoniaand VAP